The beginning is when dosing might be adjusted, and your provider will want to monitor your blood pressure, blood sugar (if you have diabetes), etc., to ensure everything is on track
however, more research is needed to determine if this observed association is causative and not a result of a third, unmeasured variable
All studies are cardiovascular outcome trials (CVOTs) and reported on MACE as their primary outcomes
Do not take two doses at once to make up for the missed one
Standard / Gradual Approach The reference approach is a loading phase to build pigment, then maintenance to hold it
The very act that the FDA sanctionscompounding a copy of a patented drug that is in shortageis the act that exposes the 503B to the greatest potential for patent litigation